- Home
- IMAB vs CLPR Comparison
IMAB vs CLPR Comparison
Compare IMAB & CLPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAB
- CLPR
- Stock Information
- Founded
- IMAB 2014
- CLPR 2015
- Country
- IMAB United States
- CLPR United States
- Employees
- IMAB N/A
- CLPR N/A
- Industry
- IMAB Biotechnology: Pharmaceutical Preparations
- CLPR Real Estate Investment Trusts
- Sector
- IMAB Health Care
- CLPR Real Estate
- Exchange
- IMAB Nasdaq
- CLPR Nasdaq
- Market Cap
- IMAB 83.8M
- CLPR 77.0M
- IPO Year
- IMAB 2020
- CLPR 2017
- Fundamental
- Price
- IMAB $1.07
- CLPR $3.97
- Analyst Decision
- IMAB Strong Buy
- CLPR Sell
- Analyst Count
- IMAB 3
- CLPR 2
- Target Price
- IMAB $8.00
- CLPR N/A
- AVG Volume (30 Days)
- IMAB 682.1K
- CLPR 225.5K
- Earning Date
- IMAB 03-13-2025
- CLPR 03-13-2025
- Dividend Yield
- IMAB N/A
- CLPR 9.57%
- EPS Growth
- IMAB N/A
- CLPR N/A
- EPS
- IMAB N/A
- CLPR N/A
- Revenue
- IMAB $3,313,984.00
- CLPR $145,595,000.00
- Revenue This Year
- IMAB N/A
- CLPR N/A
- Revenue Next Year
- IMAB N/A
- CLPR N/A
- P/E Ratio
- IMAB N/A
- CLPR N/A
- Revenue Growth
- IMAB N/A
- CLPR 6.78
- 52 Week Low
- IMAB $0.84
- CLPR $3.38
- 52 Week High
- IMAB $2.08
- CLPR $7.12
- Technical
- Relative Strength Index (RSI)
- IMAB 55.17
- CLPR 36.57
- Support Level
- IMAB $1.00
- CLPR $3.83
- Resistance Level
- IMAB $1.20
- CLPR $4.35
- Average True Range (ATR)
- IMAB 0.12
- CLPR 0.30
- MACD
- IMAB 0.02
- CLPR -0.05
- Stochastic Oscillator
- IMAB 40.97
- CLPR 10.53
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).
About CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. Clipper derives its revenue mostly from a Residential segment.